A method for the early health technology assessment of novel biomarker measurement in primary prevention programs
(Article)
Postmus, D. Graaf, G. de Hillege, H.L. Steyerberg, E.W. Buskens, E.
|
2012-10-15
|
ADDIS: A decision support system for evidence-based medicine
(Article)
Valkenhoef, G. van Tervonen, T. Zwinkels, T. Brock, B. de Hillege, H.L.
|
2012-10-15
|
Deficiencies in the transfer and availability of clinical trials evidence: A review of existing systems and standards
(Article)
Valkenhoef, G. van Tervonen, T. Brock, B. de Hillege, H.L.
|
2012-09-04
|
Multicriteria benefit-risk assessment using network meta-analysis
(Article)
Valkenhoef, G. van Tervonen, T. Zhao, J.H. Brock, B. de Hillege, H.L. Postmus, D.
|
2012-04-01
|
Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis
(Article)
Mahmoud, K.D. Vlaar, P.J. Heuvel, A.F.M. van den Hillege, H.L. Zijlstra, F.J. Smet, B.J.G.L. de
|
2011-12-15
|
Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction
(Article)
Gu, Y.L. Voors, A.A. Smet, B.J.G.L. de Zijlstra, F. Hillege, H.L. Struck, J. Masson, S. Vago, T. Anker, S.D. Heuvel, A.F.M. van den Veldhuisen, D.J. van
|
2011-12-01
|
Pediatric pulmonary hypertension in the Netherlands: Epidemiology and characterization during the period 1991 to 2005
(Article)
Loon, R.L.E. van Roofthooft, M.T.R. Mulder, B.J.M. Berger, R.M.F. Hillege, H.L. Harkel, A.D.J. ten Osch-Gevers, L. van Delhaas, T. Kapusta, L. Strengers, J.L.M. Rammeloo, L. Clur, S.A.
|
2011-10-18
|
Response to letter regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: The comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction
(Article)
Gu, Y.L. Kampinga, M.A. Horst, I.C.C. van der Smet, B.J.G.L. de Nijsten, M.W. Zijlstra, F.J. Wieringa, W.G. Fokkema, M.L. Hillege, H.L. Heuvel, A.F.M. van den Tan, E.-S. Pundziute, G. Werf, R. van der Guyomi, S.H.
|
2011-08-23
|
Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: A pairwise and network meta-analysis
(Article)
Vlaar, P.J. Mahmoud, K.D. Holmes, D.R. Valkenhoef, G. van Hillege, H.L. Horst, I.C.C. van der Zijlstra, F.J. Smet, B.J.G.L. de
|
2011-08-09
|
A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis
(Article)
Tervonen, T. Valkenhoef, G. van Buskens, E. Hillege, H.L. Postmus, D.
|
2011-05-30
|